JAKARTA, Indonesia, [29 May, 2025] – HighLight Capital (HLC), a leading investment firm, has become the lead investor in PT Tawada Healthcare's latest funding round—marking another strategic investment by HLC in Indonesia's healthcare sector. This partnership builds on Tawada's established growth trajectory, including foundational support from Capsquare Asia and a previous investment by the International Finance Corporation (IFC), a member of the World Bank Group. Through this new alliance, the partners aim to expand access to affordable, high-quality medical products and accelerate the transfer of essential healthcare technologies across Indonesia.

"Indonesia represents a cornerstone of our emerging markets healthcare strategy," said Steven Wang, CEO of HLC. "This investment in Tawada Healthcare—our fourth in Indonesia—underscores our long-term commitment to strengthening the country's medical capabilities through both technology transfer and product distribution. By integrating HLC’s global healthcare ecosystem with Tawada's nationwide network, we will deploy advanced medical technologies while expanding access to cost-effective and high-quality devices, creating a sustainable model through local capacity building across Indonesia."

The investment comes at a time of growing momentum in Indonesia's healthcare sector. With a population of over 280 million and growing demand for medical services, the government has launched a broad health system strengthening initiative focused on improving infrastructure, enhancing supply chains, and expanding service delivery. These efforts are laying the foundation for deeper collaboration between the public and private sectors. In this context, companies like Tawada Healthcare are well-positioned to contribute scalable solutions to support the country’s evolving healthcare needs.

Through this partnership, Tawada will gain access to HLC's network of leading medical device manufacturers, enabling comprehensive technology transfer while significantly broadening its product offerings. The new investment will help strengthen Tawada's logistics capabilities, distribution networks, and manufacturing capacity. This collaboration directly supports Indonesia's national health priorities, including the expansion of universal health coverage and hospital modernization programs.

Satrija Sumarkho, Founder & CEO of Tawada Healthcare noted: "This partnership combines HLC's expertise in medical technology with our nationwide distribution network, positioning us to better serve Indonesia's healthcare needs."

"This investment exemplifies IFC's commitment to mobilizing private capital for sustainable development, especially in healthcare systems where the need for innovation, accessibility, and resilience has never been greater," said Euan Marshall, IFC Country Manager for Indonesia and Timor-Leste. "By enhancing local capacity and strengthening supply chains, we aim to ensure that more Indonesians have access to the medical products and technologies they need."

Ridwan Budijono, Managing Director at Capsquare Asia and Chairman of Tawada Healthcare noted: "We applaud this important milestone in Tawada Healthcare's growth, and we will continue to work together with the Company to strengthen their position as the national leader of medical device distribution in Indonesia."

About Tawada Healthcare

Tawada Healthcare is Indonesia’s leading Medical Device Distribution company. Tawada represents more than 55 world-class brands, with access to more than 3000 accounts (hospitals, clinics, medical centers, labs), with offices in 28 locations covering the entire Indonesia, and supported by more than 700 staffs. Tawada strives to maintain its position as a dominant player in the industry, aiming to establish local manufacturing capabilities and becoming the partner of choice to all its customers, as well as advancing Indonesia’s healthcare capacity.

About HighLight Capital

HighLight Capital (HLC) is a private investment firm dedicated to creating long-term values through promoting technology innovations. Empowered by our deep knowledge in chemical, biological and material sciences, and leveraging our proprietary industry research and comprehensive enablement services, we strive to invest in companies that boost manufacturing efficiency and improve human wellness. HLC currently manages over US$3.8 billion, with operations across in key financial hubs, such as Tokyo, Shanghai, Hong Kong and Boston.

About IFC

IFC — a member of the World Bank Group — is the largest global development institution focused on the private sector in emerging markets. We work in more than 100 countries, using our capital, expertise, and influence to create markets and opportunities in developing countries. In fiscal year 2024, IFC committed a record $56 billion to private companies and financial institutions in developing countries, leveraging private sector solutions and mobilizing private capital to create a world free of poverty on a livable planet. For more information, visit www.ifc.org.   Stay Connected with IFC on social media

About Capsquare Asia

Capsquare Asia is an institutional private equity firm that focuses on investing in mid-market segment across Southeast Asia, with a particular emphasis on Indonesia. The firm represents global institutional limited partners and co-investors. With over 45 years of collective private equity experience, the general partners at Capsquare Asia have established a professional, on-the-ground team with a proven track record of success in collaborating with like-minded global and regional investors, as well as passionate founders who aspire to be national champions.